Zogenix, Inc. (NASDAQ:ZGNX) reported that Sen. Joe Manchin, D-W.Va., has asked the Department of Health and Human services to overturn the Food and Drug Administration’s decision to approve the painkiller Zohydro ER, which is made by Zogenix. Zogenix, Inc. (NASDAQ:ZGNX) stock opened at $4.03 in last session, and closed at $4.54, while the day range of stock is $4.03 – $4.68. The stock showed a positive weekly performance of 0.22%.
Bristol-Myers Squibb (NYSE:BMY) and newcomer AbbVie ($ABBV) filled out the top five with share-price growth of 63% and 50%. At the tail end, even Eli Lilly ($LLY) eked out 3% growth. Bristol-Myers Squibb Co (NYSE:BMY) stock opened at $55.99, in last session and closed at $55.83, by losing -0.55%. The 52 week range of the stock is $37.26 – $57.49. Company’s market capitalization is $92.13 billion.
hares in Merck (NYSE:MRK) have had a strong three months, up 15% while the S&P 500 has posted gains of just under 4%. However, since the bull market of March 2009 kicked off five years ago, Merck is considerably behind the wider index. Merck & Co., Inc. (NYSE:MRK) stock decreased -1.10% and finished the last session at $56.69. The EPS of the stock remained 1.48. Company’s market capitalization is $166.70 billion.
Eli Lilly & Co. (NYSE:LLY) saw unusually large options trading activity on Tuesday. Traders bought 4,581 put options on the stock, AmericanBankingNews.com reports. This is an increase of approximately 157% compared to the average volume of 1,780 put options. Eli Lilly and Co (NYSE:LLY) stock opened the session at $58.92, and closed the session at $58.43. The 52 week range of the stock remained $47.53 – $60.12 and the day range was $58.31 – $59.02.